Filing Details
- Accession Number:
- 0001209191-19-002391
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-04 21:22:24
- Reporting Period:
- 2019-01-02
- Accepted Time:
- 2019-01-04 21:22:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
827871 | Eagle Pharmaceuticals Inc. | EGRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1469124 | Scott Tarriff | C/O Eagle Pharmaceuticals, Inc. 50 Tice Blvd., Suite 315 Woodcliff Lake NJ 07677 | Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-01-02 | 6,500 | $39.30 | 1,543,459 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-01-02 | 8,500 | $40.03 | 1,534,959 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-01-03 | 10,597 | $39.04 | 1,524,362 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-01-03 | 5,670 | $39.70 | 1,518,692 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-01-03 | 302 | $40.57 | 1,518,390 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.63 to $39.615 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.63 to $40.53 inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.46 to $39.04 inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.46 to $40.35 inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.36 to $40.78 inclusive.